Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy R Galpern

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Lancet. Neurology|December 16, 2014
Clinical trials for multiple system atrophyWendy R Galpern
Current Treatment Options in Neurology|April 21, 2007
Management of impulse control disorders in Parkinson's diseaseWendy R Galpern, Mark Stacy
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Neuroprotection: lessons from a spectrum of neurological disordersWendy R Galpern, Aneesh B Singhal
Annals of Neurology|February 21, 2006
Interface between tauopathies and synucleinopathies: a tale of two proteinsWendy R Galpern, Anthony E Lang
Stroke|January 31, 2007
Screening potential therapies: lessons learned from new paradigms used in Parkinson diseaseBarbara C Tilley, Wendy R Galpern
Mitochondrion|May 9, 2007
Coenzyme Q treatment of neurodegenerative diseases of agingWendy R Galpern, Merit E Cudkowicz
Current Opinion in Neurology|June 26, 2015
Recent developments in dystoniaHyder A Jinnah, Jan K Teller, Wendy R Galpern
Clinical Pharmacology and Therapeutics|December 23, 2025
Mechanistic Population Pharmacokinetic-Pharmacodynamic Model of the Tau-Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer's DiseaseCarlos Pérez-Ruixo, Lingjue Li, Wendy R Galpern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 19, 2007
Ipratropium bromide spray as treatment for sialorrhea in Parkinson's diseaseTeri R Thomsen, Wendy R Galpern, Abena Asante, et al.
Parkinsonism & Related Disorders|July 6, 2010
Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experienceJay S Schneider, Jordan J Elm, Sotirios A Parashos, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Lancet. Neurology|December 16, 2014
Clinical trials for multiple system atrophyWendy R Galpern
Current Treatment Options in Neurology|April 21, 2007
Management of impulse control disorders in Parkinson's diseaseWendy R Galpern, Mark Stacy
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Neuroprotection: lessons from a spectrum of neurological disordersWendy R Galpern, Aneesh B Singhal
Annals of Neurology|February 21, 2006
Interface between tauopathies and synucleinopathies: a tale of two proteinsWendy R Galpern, Anthony E Lang
Stroke|January 31, 2007
Screening potential therapies: lessons learned from new paradigms used in Parkinson diseaseBarbara C Tilley, Wendy R Galpern
Mitochondrion|May 9, 2007
Coenzyme Q treatment of neurodegenerative diseases of agingWendy R Galpern, Merit E Cudkowicz
Current Opinion in Neurology|June 26, 2015
Recent developments in dystoniaHyder A Jinnah, Jan K Teller, Wendy R Galpern
Clinical Pharmacology and Therapeutics|December 23, 2025
Mechanistic Population Pharmacokinetic-Pharmacodynamic Model of the Tau-Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer's DiseaseCarlos Pérez-Ruixo, Lingjue Li, Wendy R Galpern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 19, 2007
Ipratropium bromide spray as treatment for sialorrhea in Parkinson's diseaseTeri R Thomsen, Wendy R Galpern, Abena Asante, et al.
Parkinsonism & Related Disorders|July 6, 2010
Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experienceJay S Schneider, Jordan J Elm, Sotirios A Parashos, et al.
Pageof 3